Camelot Portfolios’s CME Group CME Stock Holding History

Camelot Portfolios’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-50	Closed	-$13.7K	–	263
2025 Q4	$13.7K	Buy	+50	New	+$13.6K	0.01%	408
2024 Q3	–	Sell	-50	Closed	-$9.83K	–	222
2024 Q2	$9.83K	Buy	+50	New	+$10.3K	0.01%	414

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Camelot Portfolios's CME Position: Q1 2026 in Review

Camelot Portfolios sold out of CME Group (CME) in Q1 2026, closing a stake of 50 shares — an estimated $13.7K sold.

Camelot Portfolios first reported a position in CME in Q2 2024 and held it in 2 quarters. The position peaked at $13.7K in Q4 2025. 1,799 funds tracked by Wall St. Rank hold CME as of Q1 2026.

Camelot Portfolios reported no remaining CME Group position as of Q1 2026 after selling out during the quarter.
Camelot Portfolios sold 50 CME Group shares in Q1 2026, an estimated $13.7K.
Camelot Portfolios first reported a position in CME Group in Q2 2024 and held it in 2 quarters.
Camelot Portfolios's CME Group position peaked at $13.7K in Q4 2025.
1,799 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Camelot Portfolios's 13F filing for Q1 2026, filed 8 May 2026.